Bayer Intrauterine System (IUS) Educational Pack
Healthcare professional brochure to describe risk of ectopic pregnancy and how to differentiate between Bayer levonorgestrel IUS (LNG-IUS)
Search by company, common medicine name, or title of Risk Minimisation Material
Healthcare professional brochure to describe risk of ectopic pregnancy and how to differentiate between Bayer levonorgestrel IUS (LNG-IUS)
Information to patients about the treatment with JETREA® (ocriplasmin 0.375 mg/ 0.3 mL solution for injection)
This product has downloadable videos available to ensure that you know when and how to use Jext® correctly.
This product has additional materials to help ensure that your Jext® is always within the expiry date.
This product has downloadable videos available to ensure that you know when and how to use Jext® correctly.
Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. This guide has been developed for prescribers and healthcare professionals (HCPs) involved in the treatment of patients using Jinarc (tolvaptan). This document summarises important information on the potential risk of hepatic toxicity and provides guidance on how to manage this risk. In addition, it provides important information about pregnancy prevention before and during the treatment with Jinarc.
Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. This material is provided by Otsuka Pharmaceuticals as a licence requirement for this medicine and forms part of the Risk Management Plan.
Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. This patient alert card should be used by patients who have been prescribed medicines containing tolvaptan and should carry with them at all times when taking this medicine. This card contains important safety information that patient needs to be aware of before, during, and after treatment with Jinarc (tolvaptan).
Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. The guide should be provided to patients by the prescribing physician and includes a description of the risks of treatment, guidance on what to do in the event of risks occurring and an overview of treatment monitoring.
The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with Jylamvo (methotrexate).
This Jylamvo (methotrexate) healthcare professional guide includes important information to minimise the risk of medication error
Jyseleca (filgotinib maleate) educational material for Healthcare Professionals (HCPs) . For hard copies of this information please contact Galapagos Medical Information at [email protected] or telephone 0800 072 7878.
This Alert Card contains important safety information that patients need to be aware of before and during treatment with Jyseleca (filgotinib maleate).
Are you a healthcare professional?
Are you a healthcare professional?